In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery. (Q37232834)
Jump to navigation
Jump to search
scientific article published on 15 April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery. |
scientific article published on 15 April 2009 |
Statements
In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery (English)
Sabari Vallath
Antonio Saha
Ian R Hart
Gareth J Thomas
1 reference